Gaston Ai
Bushey
About Gaston Ai
Food is the most powerful ’ yet underused ’ lever in preventing and managing chronic disease. Over 1 billion people already live with non-communicable diseases (NCDs) like diabetes, cardiovascular disease, autoimmune conditions, etc. while billions more are unknowingly at risk. Despite clear evidence linking diet to health, today’s food system remains generic, reactive, and disconnected from individual biology. Gaston AI is changing that. We are a multi-award winning HealthTech with presence in Europe and USA. We’ve built a precision nutrition platform that uses AI, biomarkers, and clinical nutrition science to deliver real-time, personalised food decisions ’ at scale. Beyond managing allergies or restrictions, our system: Recommends foods based on metabolic markers, inflammation, and insulin sensitivity Supports those with diagnosed conditions (e.g., Type 2 diabetes, celiac) Predicts and modulates future disease risk using digital twins and longitudinal data Suggests phytonutrient-rich food patterns to optimise gene expression and long-term health Delivered via API integrations, AR-powered grocery scanning, and a medical-grade claims engine across 1,000+ use cases, Gaston AI empowers individuals to choose smarter, while enabling retailers and brands to personalise offerings, drive loyalty, and lead in the food-as-medicine revolution. We’re building a future where food isn’t guesswork ’ it’s precision healthcare.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $338.2K
- Funding stage: Seed
- Last round: Seed (Jan 2025)
- Website: gastonai.com
- Phone: +44 740 351 2511
Industries & Categories
Health Care, Machine Learning, Personal Health, Software, Wellness
Social Profiles
Canonical: https://fsome.com/organization/gaston-ai-21541 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.